This conference is provided free of charge to attendees, but registration is required. Register Now

Time Description Speaker

7:45 am

Registration/Breakfast

 

8:30 am

Introduction

Djordje Atanackovic, MD

8:35 am

Welcome

Mary Beckerle, PhD

8:40 am

Keynote Lecture: CAR T-cell Therapy For Solid Tumors

Prasad Adusumilli, MD

9:25 am

Immunological PET Imaging

Satoshi Minoshima, MD, PhD

9:45 am

Oncogenic regulation of the immune microenvironment in squamous cell lung cancer

Trudy Oliver, PhD

10:10 am

Break

 

10:25 am

Checkpoint Inhibitors in Hodgkin Lymphoma

Scott Rodig MD, PhD

11:05 am

Role of RON kinase in anti-tumor immune responses in a mouse model of breast cancer

Alana Welm PhD

11:30 am

Regulation of the Tumor Microenvironment
By Noncoding RNAs

Ryan O’Connell PhD

11:55 am

Lunch

 

12:55 pm

Key Attributes in CAR T Cell Design and Manufacture

Kevin Friedman, PhD

1:35 pm

Enhancing Antibody-Drug Conjugate Efficacy By Inducing Self-Amplifying Internalization Feedback Loops

Shawn Owen, PhD

2:00 pm

iTEP-fusions, A Drug Delivery Toolbox for Cancer Immunotherapy

Mingnan Chen, PhD

2:25 pm

Break

 

2:45 pm

CAR T Cell Therapy for Multiple Myeloma

Alfred Garfall, MD

3:25 pm

Development of CD229 CAR T cells for Multiple Myeloma

Tim Luetkens, MD

3:50 pm

Treg Post-Transplant to Improve the Therapeutic Index of Allogeneic T Cells for GVL

Michael Boyer MD

4:15 pm

Summary

Djordje Atanackovic, MD

Please contact Jeff Kenney at jeff.kenney@hci.utah.edu or 801-585-3599 if you have questions or need additional information.